March Edition of IP-Watch Monthly Reporter Now Available 08/03/2007 by Tove Iren S. Gerhardsen for Intellectual Property Watch Leave a Comment Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window)The Intellectual Property Watch Monthly Reporter features the most important news on international IP policymaking, the latest on who is coming and going in the IP community at the United Nations, World Trade Organization, Geneva missions, regional and national IP offices, industry and non-governmental organisations, plus News Briefs on reports and events that do not appear on the IP-Watch website (www.ip-watch.org). For this and more, read the Intellectual Property Watch Monthly Reporter, now available online for subscribers at: www.ip-watch.org/reporter.php. Page 1 WIPO Development Agenda Negotiation Surges Ahead Page 1 Consequences Unclear After Idris Found Misstating His Age Page 3 Consultations On GIs, Biodiversity; Enforcement On TRIPS Agenda Page 4 Cable Operators Clash With European Collecting Societies Page 4 Debate On IP And Drug Pricing Model, Flexibilities Page 5 Thai Drug Licenses Rile Industry; Talks Underway Page 6 Novartis India Legal Case Progresses Amidst Rising Opposition Page 8 IP Studies Presented At WIPO Development Agenda Side Events Page 8 Panel Features Views On Patent Flexibilities Page 9 Internet Governance Forum: The Push For Concrete Changes Page 11 News Briefs Page 12 People French and Spanish translations of certain stories are available on www.ip-watch.org. Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related "March Edition of IP-Watch Monthly Reporter Now Available" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.